Widespread Windows and Linux Vulnerabilities Could Let Attackers Sneak in Malicious Code Before Boot
VEEV, DNA and EBIX among pre-market losers
- Finance
William Murphy- 0
- 16 minutes read
- Losers: Atara Biotherapeutics (ATRA) -58% falls 50% after-hours on failed Phase 2 study for MS drug.
- Assertio Holdings (ASRT) -46% after Q3 earning release.
- Cardlytics (CDLX) -36% after Q3 earning release.
- Inspired Entertainment (INSE) -31%.
- Ebix (EBIX) -29%.
- NuScale Power Corporation (SMR) -26% after Q3 earning release.
- Topgolf Callaway Brands Corp (MODG) -22% after Q3 earning release.
- Amylyx Pharmaceuticals (AMLX) -17%. after Q3 earning release.
- Digital Turbine (APPS) -12% after Q2 earning release.
- BILL Holdings (BILL) -11% on report of $1.95B deal talks for Melio Payments.
- CCC Intelligent Solutions Holdings (CCCS) -9% proposes secondary offering of 50M shares, including concurrent. repurchases
- Liveperson (LPSN) -9% after Q3 earning release.
- Luminar Technologies (LAZR) -8% after Q3 earning release.
- Ginkgo Bioworks Holdings (DNA) -9% after Q3 earning release.
- IonQ (IONQ) -8% after Q3 earning release.
- scPharmaceuticals (SCPH) -8% after Q3 earning release.
- Veeva Systems (VEEV) -7%.
- Biolase (BIOL) -7%.
- Globavend Holdings Limited (GVH) -7%.
- Smith Micro Software (SMSI) -7% after Q3 earning release.
- Arm Holdings (ARM) -6% after Q2 earning release.
- AerSale Corp (ASLE) -6% after Q3 earning release.
Comments
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.